




Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
In the Agar Diffusion Method, also known as the Kirby-Bauer Test, a Petri plate containing an agar medium is inoculated, "seeded", uniformly over the entire ...
Typology: Lecture notes
1 / 8
This page cannot be seen from the preview
Don't miss anything!
Introduction Antimicrobial drugs are a class of chemotherapeutic agents used in the treatment of infectious diseases. They can generally be divided into four groups as follows: 1) synthetic antimicrobial drugs ,
Data used to generate this type of breakpoint are obtained from multiple in vitro MIC tests. Bacterial strains are designated as “wild type” if they show no resistance to the drug being examined, or drugs with the same mechanism/site of action. Clinical breakpoints refer to those concentrations (MICs) that separate strains where there is a high likelihood of treatment success from those where treatment is more likely to fail, and are based on results obtained during multiple clinical trials. A third use of the term breakpoint can be applied to the therapeutic dose , i.e., the concentration of an antimicrobial drug expected to yield clinical control of a particular pathogen within the human body. This must integrate drug potency against specific populations of potential pathogens with the pharmacokinetics ( PK )/ pharmacodynamics ( PD ) of antimicrobial agents (what happens to drugs inside the body due to metabolic processes). The accurate determination of therapeutic dose must take into account in vivo complexities such as dosing schedule, the site of infection, likely PK/PD of the drug within a specific individual, adequacy of host defenses and a range of other factors. Typically PK/PD breakpoints are determined using data generated in animal models and then extrapolated to humans using mathematical or statistical techniques. Breakpoints must be continuously monitored and modified because mutations and gene transfer mechanisms allow potential pathogens to survive the selective pressures exerted by human application of antimicrobial agents (evolution happens). A list of organizations involved in setting breakpoints can be found at: http://cmr.asm.org/content/20/3/391/T1.expansion.html Note – Antimicrobial drugs are sometimes used in the identification of microorganisms, since certain species are more or less susceptible to particular drugs. For example, Streptococcus pyogenes is sensitive to Bacitracin (0.04 units per disc) while other pathogenic streptococci are not. In addition, certain drugs may be added to media to inhibit the growth of unwanted contaminants or to insure that the only cells growing are carrying specific "marker" genes. Procedure:
Kirby-Bauer Method (Significance of Zone Diameters When Using High Potency Antimicrobial Sensitivity Disks) Antimicrobial Disk R I S Agent Potency Resistant Intermediate Sensitive mm. mm. mm.
Amikacin 10 mcg <12 12 - 13 > Ampicillin Gram-negative 10 mcg <12 12 - 13 > and enterococci Staphylococci & pcn G 10 mcg <21 21 - 28 > susceptibles Bacitracin 10 units < 9 9 - 12 > Carbenicillin Proteus sp. and E. coli 50 mcg <18 18 - 22 > Pseudomonas aeruginosa 50 mcg <13 13 - 14 > Cephalothin For cephaloglycin only 30 mcg <15 > For other cephalosporins 30 mcg <15 15 - 17 > Chloramphenicol 30 mcg <13 13 - 17 > Clindamycin 2 mcg <15 15 - 16 > Colistin 1 0 mcg < 9 9 - 10 > Erythromycin 15 mcg <14 14 - 17 > Gentamicin for P. aeruginosa 10 mcg <13 > Kanamycin 30 mcg <14 14 - 17 > Lincomycin (Clindamycin) 2 mcg <17 17 - 20 > Methicillin (Penicillinase-resistant 5 mcg <10 10 - 13 > penicillin class) Nafcillin 1 mcg <11 11 - 12 > Nalidixic Acid 30 mcg <14 14 - 18 > Neomycin 30 mcg <13 13 - 16 > Nitrofurantoin 300 mcg <15 15 - 16 > Novobiocin 30 mcg <18 18 - 21 > Oleandomycin 15 mcg <21 18 - 21 > Oxolinic Acid 2 mcg <11 > Penicillin G for staphylococci 10 units <21 21 - 28 > For other organisms 10 units <12 12 - 21 > Polymyxin B 300 units < 9 9 - 11 > Rifampin for S. pneumoniae 5 mcg <16 17 - 18 > For other organisms 5 mcg <16 17 - 19 > Streptomycin 10 mcg <12 12 - 14 > Tetracycline 30 mcg <15 15 - 18 >1 8 Tobramycin 10 mcg <12 12 - 13 > Triple Sulfa 350 mcg <12 13 - 16 > Vancomycin 30 mcg <10 10 - 11 >
AM- 10 Ampicillin E- 15 Erythromycin OA- 2 Oxolinic Acid AN- 10 Amikacin FM- 300 Nitrofurantoin OL- 15 Oleandomycin B- 10 Bacitracin GM- 10 Gentamycin P- 10 Penicillin G C- 30 Chloramphenicol K- 30 Kanamycin PB- 300 Polymyxin B CB- 50 Carbenicillin L- 2 Lincomycin RA- 5 Rifampin CB- 100 Carbenicillin N- 30 Neomycin S- 10 Streptomycin CC- 2 Clindamycin NA- 30 Nalidixic Acid SSS- 25 Triple Sulfonamides CF- 30 Cephalothin NB- 30 Novobiocin Te- 30 Tetracycline CL- 10 Colistin NF- 1 Nafcillin Va- 30 Vancomycin DP- 5 Methicillin NN- 10 Tobramycin
A Aureomycin GM Gentamycin PB Polymyxin B Am Ampicillin K Kanamycin RA Rifampin An Amikacin L Lincomycin S Streptomycin B Bacitracin LR Cephaloridine SD Sufadiazine C Chloromycetin ME Methicillin SSS Triple Sulfa CB Carbenicillin N Neomycin SM Sulfamerazine CC Clindamycin NA Nalidixic Acid ST Sulfathiazole CL Colistin NB Novobiocin T Terramycin CR Cephalothin NF Nafcillin TE Tetracycline CX Cloxacillin OA Oxolinic Acid TM Tobramycin E Erythromycin OL Oleandomycin V Viomycin FD Nitrofurantoin P Penicillin G VA Vancomycin
Name ________________________________ Lab Section ________________ WORKSHEET Exercise 24B Antimicrobial Sensitivity Testing Goals : ___________________________________________________________________________
Materials & Methods: The Kirby-Bauer antimicrobial sensitivity procedure was followed. Organism type used: ________________________________________________________________ Medium used: _____________________________________________________________________ Incubation temperature: ________________ Duration of incubation: __________________________ Data & Results: Antimicrobial Agent Zone of Inhibition R, I, or S? Conclusions: